title: Hodgkin disease subsequent to follicular lymphoma on maintenance rituximab.
authors.forename: Laura
authors.initials: L
authors.lastname: Scaramucci
authors.forename: Alessio
authors.initials: A
authors.lastname: Perrotti
authors.forename: Pasquale
authors.initials: P
authors.lastname: Niscola
authors.forename: Stefano
authors.initials: S
authors.lastname: Fratoni
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Palombi
authors.forename: Daniela
authors.initials: D
authors.lastname: Piccioni
authors.forename: Luca
authors.initials: L
authors.lastname: Cupelli
authors.forename: Andrea
authors.initials: A
authors.lastname: Tendas
authors.forename: Teresa
authors.initials: T
authors.lastname: Dentamaro
authors.forename: Giovanni
authors.initials: G
authors.lastname: Del Poeta
authors.forename: Paolo
authors.initials: P
authors.lastname: De Fabritiis
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000473:pathology*; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D000069283:Rituximab